The role of cGMP in ocular growth and the development of form-deprivation myopia in guinea pigs

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 13, 2013, Pages 7887-7902

  Fang, Fang ^a,c   Pan, Miaozhen ^a,b   Yan, Tingting ^a,b   Tao, Yijin ^a,b   Wu, Hao ^a,b   Liu, Xing ^a,b   Qu, Jia ^a,b   Zhou, Xiangtian ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b State Key Laboratory Cultivation Base and Key Laboratory of Vision Science   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

BAY41 2272; cGMP; Form deprived myopia; Guinea pigs; NS 2028

Indexed keywords

4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO [3, 4 B] PYRIDIN 3 YL] PYRIMIDINE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; CYCLIC GMP; GUANYLATE CYCLASE; NS 2028; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; EYE AXIS LENGTH; EYE REFRACTION; GUINEA PIG; MYOPIA; NONHUMAN; PRIORITY JOURNAL; VISUAL DEPRIVATION; VISUAL STIMULATION; VITREOUS BODY;

BAY41-2272; CGMP; FORM-DEPRIVED MYOPIA; GUINEA PIGS; NS-2028;

ANIMALS; COLLAGEN; CONJUNCTIVA; CYCLIC GMP; DISEASE PROGRESSION; EYE; GUANYLATE CYCLASE; GUINEA PIGS; INJECTIONS; MYOPIA; OXADIAZOLES; OXAZINES; RADIOIMMUNOASSAY; RETINA; SCLERA; SENSORY DEPRIVATION;

EID: 84889588978     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-11999     Document Type: Article

References (73)

1. Lin LL, Shih YF, Tsai CB, et al. Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995. Optom Vis Sci. 1999;76:275-281.
2. Lin LL, Shih YF, Hsiao CK, Chen CJ. Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore. 2004;33:27-33.
3. Celorio JM, Pruett RC. Prevalence of lattice degeneration and its relation to axial length in severe myopia. Am J Ophthalmol. 1991;111:20-23.
4. Miller DG, Singerman LJ. Natural history of choroidal neovascularization in high myopia. Curr Opin Ophthalmol. 2001;12:222-224.
5. Zadnik K. The Glenn A. Fry Award Lecture (1995). Myopia development in childhood. Optom Vis Sci. 1997;74:603-608.
6. Leng Y, Lan W, Yu K, et al. Effects of confined space and near vision stimulation on refractive status and vitreous chamber depth in adolescent rhesus monkeys. Sci China Life Sci. 2010; 53:1433-1439.
7. Saw SM, Chua WH, Gazzard G, Koh D, Tan DT, Stone RA. Eye growth changes in myopic children in Singapore. Br J Ophthalmol. 2005;89:1489-1494.
8. McBrien NA, Lawlor P, Gentle A. Scleral remodeling during the development of and recovery from axial myopia in the tree shrew. Invest Ophthalmol Vis Sci. 2000;41:3713-3719.
9. McBrien NA, Gentle A. Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res. 2003;22:307-338.
10. McBrien NA, Metlapally R, Jobling AI, Gentle A. Expression of collagen-binding integrin receptors in the mammalian sclera and their regulation during the development of myopia. Invest Ophthalmol Vis Sci. 2006;47:4674-4682.
11. Norton TT, Rada JA. Reduced extracellular matrix in mammalian sclera with induced myopia. Vision Res. 1995;35:1271-1281.
12. Rada JA, Nickla DL, Troilo D. Decreased proteoglycan synthesis associated with form deprivation myopia in mature primate eyes. Invest Ophthalmol Vis Sci. 2000;41:2050-2058.
13. Troilo D, Nickla DL, Mertz JR, Summers Rada JA. Change in the synthesis rates of ocular retinoic acid and scleral glycosaminoglycan during experimentally altered eye growth in marmosets. Invest Ophthalmol Vis Sci. 2006;47:1768-1777.
14. McBrien NA, Cornell LM, Gentle A. Structural and ultrastructural changes to the sclera in a mammalian model of high myopia. Invest Ophthalmol Vis Sci. 2001;42:2179-2187.
15. Wu J, Liu Q, Yang X, Yang H, Wang XM, Zeng JW. Time-course of changes to nitric oxide signaling pathways in formdeprivation myopia in guinea pigs. Brain Res. 2007;1186: 155-163.
16. Francis SH, Corbin JD. Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase. Adv Pharmacol. 1994;26:115-170.
17. Murad F. Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci Rep. 1999;19:133-154.
18. Dooley A, Gao B, Shi-Wen X, et al. Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts. Free Radic Biol Med. 2007;43: 253-264.
19. Hsu YC, Hsiao M, Chien YW, Lee WR. Exogenous nitric oxide stimulated collagen type I expression and TGF-beta1 production in keloid fibroblasts by a cGMP-dependent manner. Nitric Oxide. 2007;16:258-265.
20. Li P, Wang D, Lucas J, et al. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res. 2008;102:185-192.
21. Lu F, Zhou X, Zhao H, et al. Axial myopia induced by a monocularly-deprived facemask in guinea pigs: A non-invasive and effective model. Exp Eye Res. 2006;82:628-636.
22. Zhou X, Lu F, Xie R, et al. Recovery from axial myopia induced by a monocularly deprived facemask in adolescent (7-weekold) guinea pigs. Vision Res. 2007;47:1103-1111.
23. Kalsi JS, Rees RW, Hobbs AJ, et al. BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro. J Urol. 2003; 169:761-766.
24. Olesen SP, Drejer J, Axelsson O, et al. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br J Pharmacol. 1998;123:299-309.
25. Jiang L, Long K, Schaeffel F, et al. Disruption of emmetropization and high susceptibility to deprivation myopia in albino guinea pigs. Invest Ophthalmol Vis Sci. 2011;52:6124-6132.
26. Schaeffel F, Howland HC. Properties of the feedback loops controlling eye growth and refractive state in the chicken. Vision Res. 1991;31:717-734.
27. Melenovsky V, Al-Hiti H, Kazdova L, et al. Transpulmonary Btype natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. J Am Coll Cardiol. 2009;54:595-600.
28. Shin JA, Kim IB, Lee HY. Changes in retinal neurons in the guinea pig retina stimulated by strobe lights during development. Neurosci Lett. 2012;531:57-62.
29. Dong F, Zhi Z, Pan M, et al. Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs. Mol Vis. 2011;17:2824-2834.
30. Wiley JL, Buhler KG, Lavecchia KL, Johnson KM. Pharmacological challenge reveals long-term effects of perinatal phencyclidine on delayed spatial alternation in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:867-873.
31. Xu M, Guo Y, Vorhees CV, Zhang J. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res. 2000;852:198-207.
32. Fujikado T, Kawasaki Y, Fujii J, et al. The effect of nitric oxide synthase inhibitor on form-deprivation myopia. Curr Eye Res. 1997;16:992-996.
33. Fujikado T, Tsujikawa K, Tamura M, Hosohata J, Kawasaki Y, Tano Y. Effect of a nitric oxide synthase inhibitor on lensinduced myopia. Ophthalmic Res. 2001;33:75-79.
34. Bedrossian RH. The effect of atropine on myopia. Ophthalmology. 1979;86:713-719.
35. Chou AC, Shih YF, Ho TC, Lin LL. The effectiveness of 0.5% atropine in controlling high myopia in children. J Ocul Pharmacol Ther. 1997;13:61-67.
36. Siatkowski RM, Cotter SA, Crockett RS, Miller JM, Novack GD, Zadnik K. Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. J AAPOS. 2008;12:332-339.
37. Luft WA, Ming Y, Stell WK. Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. Invest Ophthalmol Vis Sci. 2003;44:1330-1338.
38. McBrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci. 1993;34: 205-215.
39. Metlapally S, McBrien NA. The effect of pirenzepine on positive-and negative-lens-induced refractive error and ocular growth in chicks. Invest Ophthalmol Vis Sci. 2010;51:5438-5444.
40. Stone RA, Lin T, Laties AM. Muscarinic antagonist effects on experimental chick myopia. Exp Eye Res. 1991;52:755-758.
41. Castoldi AF, Manzo L, Costa LG. Cyclic GMP formation induced by muscarinic receptors is mediated by nitric oxide synthesis in rat cortical primary cultures. Brain Res. 1993;610:57-61.
42. Hawdon JM, Datu B. The second messenger cyclic GMP mediates activation in Ancylostoma caninum infective larvae. Int J Parasitol. 2003;33:787-793.
43. Avetisov ES, Savitskaya NF, Vinetskaya MI, Iomdina EN. A study of biochemical and biomechanical qualities of normal and myopic eye sclera in humans of different age groups. Metab Pediatr Syst Ophthalmol. 1983;7:183-188.
44. Redondo J, Bishop JE, Wilkins MR. Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts. Br J Pharmacol. 1998;124:1455-1462.
45. Obayashi K, Akamatsu H, Okano Y, Matsunaga K, Masaki H. Exogenous nitric oxide enhances the synthesis of type I collagen and heat shock protein 47 by normal human dermal fibroblasts. J Dermatol Sci. 2006;41:121-126.
46. Wang Y, Kramer S, Loof T, et al. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition. Am J Physiol Renal Physiol. 2006;290:F167-176.
47. Zhou XT, Tao YJ, Pan MZ, et al. cAMP regulates visual development and myopia occurrence in guinea pigs probably via reducing scleral collagen synthesis. Invest Ophthalmol Vis Sci. 2012;53:4661.
48. Pelligrino DA, Wang Q. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol. 1998;56: 1-18.
49. Zaccolo M, Movsesian MA. cAMP and cGMP signaling crosstalk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res. 2007;100:1569-1578.
50. Stief CG, Uckert S, Becker AJ, et al. Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology. 2000;55:146-150.
51. Bonomi L, Fregona I, Tomazzoli L. Cyclic guanosine monophosphate (GMP) levels in ocular tissues. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977;205:23-27.
52. Stein PJ, Clack JW. Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits. Invest Ophthalmol Vis Sci. 1994;35:2765-2768.
53. Shahidullah M, Wilson WS. Atriopeptin, sodium azide and cyclic GMP reduce secretion of aqueous humour and inhibit intracellular calcium release in bovine cultured ciliary epithelium. Br J Pharmacol. 1999;127:1438-1446.
54. Kotikoski H, Alajuuma P, Moilanen E, et al. Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J Ocul Pharmacol Ther. 2002;18:11-23.
55. Kotikoski H, Kankuri E, Vapaatalo H. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure. Med Sci Monit. 2003;9:BR1-BR7.
56. Lee AJ, Saw SM, Gazzard G, Cheng A, Tan DT. Intraocular pressure associations with refractive error and axial length in children. Br J Ophthalmol. 2004;88:5-7.
57. Schmid KL, Abbott M, Humphries M, Pyne K, Wildsoet CF. Timolol lowers intraocular pressure but does not inhibit the development of experimental myopia in chick. Exp Eye Res. 2000;70:659-666.
58. Puell-Marin MC, Romero-Martin M, Dominguez-Carmona M. Intraocular pressure in 528 university students: effect of refractive error. J Am Optom Assoc. 1997;68:657-662.
59. Quinn GE, Berlin JA, Young TL, Ziylan S, Stone RA. Association of intraocular pressure and myopia in children. Ophthalmology. 1995;102:180-185.
60. Liu JH, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in young adults with moderate to severe myopia. Invest Ophthalmol Vis Sci. 2002;43:2351-2355.
61. Edwards MH, Brown B. IOP in myopic children: the relationship between increases in IOP and the development of myopia. Ophthalmic Physiol Opt. 1996;16:243-246.
62. Cobbs WH, Barkdoll AE 3rd, Pugh EN Jr. Cyclic GMP increases photocurrent and light sensitivity of retinal cones. Nature. 1985;317:64-66.
63. Ding JD, Weinberg RJ. Distribution of soluble guanylyl cyclase in rat retina. J Comp Neurol. 2007;502:734-745.
64. Sitaramayya A. Soluble guanylate cyclases in the retina. Mol Cell Biochem. 2002;230:177-186.
65. Frost MR, Norton TT. Alterations in protein expression in tree shrew sclera during development of lens-induced myopia and recovery. Invest Ophthalmol Vis Sci. 2012;53:322-336.
66. Gao H, Frost MR, Siegwart JT Jr, Norton TT. Patterns of mRNA and protein expression during minus-lens compensation and recovery in tree shrew sclera. Mol Vis. 2011;17:903-919.
67. Xu H, Chen M, Forrester JV, Lois N. Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion. Invest Ophthalmol Vis Sci. 2011;52:249-255.
68. Forrester JV, Worgul BV, Merriam GR Jr. Endotoxin-induced uveitis in the rat. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980;213:221-233.
69. Buck C, Schaeffel F, Simon P, Feldkaemper M. Effects of positive and negative lens treatment on retinal and choroidal glucagon and glucagon receptor mRNA levels in the chicken. Invest Ophthalmol Vis Sci. 2004;45:402-409.
70. Fischer AJ, McGuire JJ, Schaeffel F, Stell WK. Light-and focusdependent expression of the transcription factor ZENK in the chick retina. Nat Neurosci. 1999;2:706-712.
71. Bitzer M, Schaeffel F. Defocus-induced changes in ZENK expression in the chicken retina. Invest Ophthalmol Vis Sci. 2002;43:246-252.
72. Siegwart JT, Jr., Norton TT. The time course of changes in mRNA levels in tree shrew sclera during induced myopia and recovery. Invest Ophthalmol Vis Sci. 2002;43:2067-2075.
73. Howlett MH, McFadden SA. Form-deprivation myopia in the guinea pig (Cavia porcellus). Vision Res. 2006;46:267-283.